Beryl Drugs Key Metrics

BSE: 524606 | NSE: - | ISIN: INE415H01017 | Sector: Biotechnology & Drugs

19.14 0.00 (0.00%)Updated : 11 Jun 2025

Ratios

Return on average equity - 5 year average	4.15
Net Income/employee - trailing 12 month	0.00
Revenue/employee - most recent fiscal year	0.00
Return on investment - most recent fiscal year	4.95
Return on average assets - most recent fiscal year	3.46
Receivables turnover - most recent fiscal year	3.24
Return on investment - trailing 12 month	4.95
Return on average assets - trailing 12 month	3.46
Inventory turnover - most recent fiscal year	6.82
Inventory turnover - trailing 12 month	6.82
Revenue/employee - trailing 12 month	0.00
Return on average assets - 5 year average	1.93
Net Income/employee - most recent fiscal year	0.00
Return on average equity - trailing 12 month	6.28
Receivables turnover - trailing 12 month	3.24
Asset turnover - most recent fiscal year	1.26
Asset turnover - trailing 12 month	1.26
Return on average equity - most recent fiscal year	6.28
Return on investment - 5 year average	3.16